Introduction

Definition of ARVC

Arrhythmogenic Right Ventricular Cardiomyopathy or ARVC is a cardiac muscle disease in which normal tissues get replaced by fatty fibrous tissues, affecting heart health, and may result in irregular heartbeats that can be life-threatening.

Overview of its impact on heart structure and function

Heart structure is impaired because of muscle physiology changes that may affect a particular part of the heart but can also affect other parts, which may result in heart weakening and heart failure.

Importance of understanding heart size in ARVC

Heart size study is crucial for the following reasons:

1. Early Detection of Disease Progression
2. Assessment of Right Ventricular Dysfunction
3. Prediction of Heart Failure Risk
4. Monitoring for Arrhythmias
5. Guiding Treatment and Management Decisions
6. Prognosis and Long-term Monitoring
7. Differentiating ARVC from Other Heart Conditions
8. Patient Quality of Life
9. Genetic Counseling &  Family Risk Assessment
10. Tracking the Effectiveness of Treatment

Pathophysiology of ARVC

Genetic causes include mutated genes, primarily as a result of autosomal dominant genes that make genes defective, resulting in ARVC, making it highly risky because of higher prevalence in the next generation. 

Progressive fibrofatty replacement of the myocardium, especially in the right ventricle (RV), is a prominent physiological sign for ARVC.

Initial changes in heart size

Early stages: In the early stages, the heart size is normal, often leading to a misdiagnosis. 

Enlargement of the right ventricle (RV) due to progressive damage can be observed over time, showing structural changes in heart size, making the right ventricle pump effectively for short periods but weakening it in the long run.

Right ventricle (RV) and its impact on heart size

Right ventricular dilation

The right ventricle is a highly affected chamber that undergoes the following changes:

• Myocardial integrity is lost
• Right ventricle enlargement
• Decreased contractility 
• Impaired pumping function
• Potential for right-sided heart failure

Left ventricle (LV) involvement

Secondary involvement in later stages (in some cases) in advanced stages, making structural changes in the left ventricle. Left ventricular enlargement and dysfunction begin to occur if ARVC progresses. Compensatory changes in the left ventricle to maintain overall cardiac output, thus the heart becomes stressed, and overall functions are disturbed.

Structural abnormalities

• Fibrosis 
• Fat infiltration 
• Remodeling of both right 
• Remodeling of the left ventricular walls
• Altered heart geometry, affecting overall heart size

Functional implications

• Decreased ejection fraction, particularly from the right ventricle
• Potential for arrhythmias (irregular heartbeat) that can affect cardiac function and size over time
• Reduced stroke volume due to impaired heart muscle contraction

Diagnostic imaging and monitoring heart size

Some diagnostic procedures and imaging techniques are helpful in the diagnosis, as follows:

• Use of echocardiography
• MRI
• CT scans to monitor changes in heart size and structure
• RV end-diastolic volume (EDV) is known as an important marker of ARVC progression
• Left ventricle dimensions in cases of advanced ARVC

Clinical implications

The risk of arrhythmias, including ventricular tachycardia and fibrillation, is most common in cases of ARVC  due to an altered heart structure that can be life-threatening. measures are needed. There is a potential need for heart transplantation in severe cases because structural changes in cardiac muscles are irreversible. Early detection of the disease and regular monitoring to manage heart size, along with preventive measures, can lower the risks of ARVC.

Summary

ARVC is a life-threatening genetic disorder. It is known to make structural changes in heart size that are not easily detectable in the initial stages. Hence, its impact on heart pumping action can result in heart failure. These changes are irreversible and can be managed symptomatically. In severe cases, heart transplantation can be considered. However, it can be prevented by genetic counseling and educational awareness among the community to reduce its occurrence.

FAQs

Is ARVC reversible, or can the enlargement be reduced?

The structural changes caused by ARVC, such as right ventricular dilation, are typically not reversible. However, treatment can help manage symptoms, control arrhythmias, and slow the progression of the disease. This includes medications, lifestyle modifications, and sometimes surgical interventions like implantation of a defibrillator.

Can ARVC affect the left ventricle?

While ARVC primarily affects the right ventricle, in some cases, the left ventricle can also become involved, especially in more advanced stages of the disease. This can result in more significant heart enlargement and further complications.

What diagnostic tests can measure changes in heart size due to ARVC?

Imaging tests such as echocardiography (ultrasound of the heart), MRI (magnetic resonance imaging), or CT scans are used to measure the size of the heart chambers and evaluate the function of the right ventricle. These tests can help doctors monitor changes in heart size over time and guide treatment decisions.

Does ARVC cause heart enlargement in every patient?

No, not all patients with ARVC will experience significant heart enlargement. The extent of right ventricular enlargement and the degree of heart involvement vary from person to person, depending on the severity and progression of the disease.

Can early detection help prevent heart enlargement in ARVC?

Early diagnosis and treatment can help manage the condition and reduce the risk of complications, including significant heart enlargement. Regular monitoring through imaging and tests is important to track changes in heart size and function.

What are the treatment options to manage ARVC and its effect on heart size?

Treatment for ARVC aims to manage symptoms, prevent arrhythmias, and prevent further deterioration of heart function. This may include medications (e.g., beta-blockers, antiarrhythmic drugs), implantable cardioverter-defibrillators (ICDs) for arrhythmia prevention, and lifestyle changes. In some cases, surgery or heart transplantation may be considered if the condition leads to severe heart failure.